The link between depression and diabetes: The search for shared mechanisms

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 6, 2015, Pages 461-471

  Moulton, Calum D ^a   Pickup, John C ^a   Ismail, Khalida ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; CELECOXIB; CYTOKINE; GLUCOSE TRANSPORTER 4; INSULIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; KYNURENINE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIOGLITAZONE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA; GLUCOSE BLOOD LEVEL;

ADOLESCENT DISEASE; ADULTHOOD; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; CYTOKINE RESPONSE; DEPRESSION; DISEASE ASSOCIATION; EGO DEVELOPMENT; FAMILY RELATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

BLOOD GLUCOSE; CIRCADIAN RHYTHM; COMORBIDITY; CYTOKINES; DEPRESSION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNITY, INNATE; INSULIN; INSULIN RESISTANCE; PITUITARY-ADRENAL SYSTEM;

EID: 84929962639     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00134-5     Document Type: Review

References (109)

1. Willis T Diabetes: A Medical Odyssey 1971, USV Pharmaceutical Corp, Tuckahoe, New York.
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
3. Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustün TB Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 2007, 20:359-364.
4. Wing JK, Babor T, Brugha T, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990, 47:589-593.
5. Twist K, Stahl D, Amiel SA, Thomas S, Winkley K, Ismail K Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design. Psychosom Med 2013, 75:791-797.
6. Snoek FJ, Bremmer MA, Hermanns N Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol 2015, published online May 18. http://dx.doi.org/10.1016/S2213-8587(15)00135-7.
7. Katon WJ, Russo JE, Heckbert SR, et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry 2010, 25:466-475.
8. Nouwen A, Nefs G, Caramlau I, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium. Diabetes Care 2011, 34:752-762. the European Depression in Diabetes Research Consortium.
9. Colman I, Jones PB, Kuh D, et al. Early development, stress and depression across the life course: pathways to depression in a national British birth cohort. Psychol Med 2014, 44:2845-2854.
10. Scott KM, Von Korff M, Angermeyer MC, et al. Association of childhood adversities and early-onset mental disorders with adult-onset chronic physical conditions. Arch Gen Psychiatry 2011, 68:838-844.
11. Heraclides A, Chandola T, Witte DR, Brunner EJ Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: evidence from the Whitehall II study. Diabetes Care 2009, 32:2230-2235.
12. Stansfeld SA, Shipley MJ, Head J, Fuhrer R Repeated job strain and the risk of depression: longitudinal analyses from the Whitehall II study. Am J Public Health 2012, 102:2360-2366.
13. Katon WJ, Lin EH, Russo J, et al. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med 2004, 19:1192-1199.
14. Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 2014, 37:625-633.
15. Katon WJ, Von Korff M, Lin EH, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61:1042-1049.
16. Katon W, Russo J, Lin EH, et al. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry 2012, 69:506-514.
17. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:934-942.
18. Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010, 33:23-28.
19. Palta P, Golden SH, Teresi JA, et al. Depression is not associated with diabetes control in minority elderly. J Diabetes Complications 2014, 28:798-804.
20. Aikens JE, Perkins DW, Lipton B, Piette JD Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care 2009, 32:1177-81.21.
21. Ting RZ, Lau ES, Ozaki R, et al. High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression-a 7-year prospective analysis of the Hong Kong Diabetes Registry. J Affect Disord 2013, 149:129-135.
22. Sullivan MD, Katon WJ, Lovato LC, et al. Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiatry 2013, 70:1041-1047.
23. Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010, 53:2480-2486. the European Depression in Diabetes (EDID) Research Consortium.
24. Mezuk B, Eaton WW, Albrecht S, Golden SH Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-2390.
25. Scherrer JF, Xian H, Lustman PJ, et al. A test for common genetic and environmental vulnerability to depression and diabetes. Twin Res Hum Genet 2011, 14:169-172.
26. Eftychi C, Howson JM, Barratt BJ, et al. Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in Type 1 diabetes. Diabetes 2004, 53:870-873.
27. Ji-Rong Y, Bi-Rong D, Chang-Quan H, et al. Pro12Ala polymorphism in PPARγ2 associated with depression in Chinese nonagenarians/centenarians. Arch Med Res 2009, 40:411-415.
28. Liu Y, Murphy SK, Murtha AP, et al. Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics 2012, 7:735-746.
29. Barker DJ, Eriksson JG, Forsén T, Osmond C Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002, 31:1235-1239.
30. de Mola CL, de França GV, Quevedo LA, Horta BL Low birth weight, preterm birth and small for gestational age association with adult depression: systematic review and meta-analysis. Br J Psychiatry 2014, 205:340-347.
31. Pickup JC, Crook MA Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
32. Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2013, 36:166-175.
33. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007, 356:1517-1526.
34. Goldfine AB, Fonseca V, Jablonski KA, et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann Intern Med 2013, 159:1-12. the Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team.
35. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
36. Hoyo-Becerra C, Schlaak JF, Hermann DM Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation. Brain Behav Immun 2014, 42:222-231.
37. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
38. Na KS, Lee KJ, Lee JS, Cho YS, Jung HY Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2014, 48:79-85.
39. British National Formulary 2013, Pharmaceutical Press, London, UK. 67th ed.
40. Laake JP, Stahl D, Amiel SA, et al. The association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care 2014, 37:2186-2192.
41. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
42. Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry 2014, 71:1121-1128.
43. Hayashino Y, Mashitani T, Tsujii S, Ishii H Elevated levels of hs-CRP are associated with high prevalence of depression in Japanese patients with type 2 diabetes: the Diabetes Distress and Care Registry at Tenri (DDCRT 6). Diabetes Care 2014, 37:2459-2465. the Diabetes Distress and Care Registry at Tenri Study Group.
44. Duivis HE, Kupper N, Penninx BW, Na B, de Jonge P, Whooley MA Depressive symptoms and white blood cell count in coronary heart disease patients: prospective findings from the Heart and Soul Study. Psychoneuroendocrinology 2013, 38:479-487.
45. Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 2014, 129:1350-1369. the American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing.
46. Marioni RE, Strachan MW, Reynolds RM, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010, 59:710-713.
47. Lu S, Peng H, Wang L, et al. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis. Compr Psychiatry 2013, 54:953-961.
48. Stringhini S, Batty GD, Bovet P, et al. Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: the Whitehall II prospective cohort study. PLoS Med 2013, 10:e1001479.
49. Kyrou I, Tsigos C Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol 2009, 9:787-793.
50. Coderre L, Vallega GA, Pilch PF, Chipkin SR In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol 1996, 271:E643-E648.
51. Chrousos GP The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000, 24(suppl 2):S50-S55.
52. Herbert J, Goodyer IM, Grossman AB, et al. Do corticosteroids damage the brain?. J Neuroendocrinol 2006, 18:393-411.
53. Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CHY Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav 2015, published online Jan 7. 10.1007/s11682-014-9348-2.
54. Frodl T, Carballedo A, Hughes MM, et al. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Transl Psychiatry 2012, 2:e88.
55. Stetler C, Miller GE Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011, 73:114-126.
56. Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology 2009, 34:1208-1213.
57. Strickland PL, Deakin JF, Percival C, Dixon J, Gater RA, Goldberg DP Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br J Psychiatry 2002, 180:168-173.
58. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, Kim DM The neurobiological consequences of early stress and childhood maltreatment. Neurosci Biobehav Rev 2003, 27:33-44.
59. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000, 284:592-597.
60. Scharnholz B, Gilles M, Marzina A, et al. Do depressed patients without activation of the hypothalamus-pituitary-adrenal (HPA) system have metabolic disturbances?. Psychoneuroendocrinology 2014, 39:104-110.
61. Wu TC, Chen HT, Chang HY, et al. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 2013, 38:871-883.
62. Otte C, Hinkelmann K, Moritz S, et al. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res 2010, 44:339-346.
63. Swaminathan K, Davies J, George J, Rajendra NS, Morris AD, Struthers AD Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. Diabetologia 2008, 51:762-768.
64. Kan C, Silva N, Golden SH, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013, 36:480-489.
65. Everson-Rose SA, Meyer PM, Powell LH, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004, 27:2856-2862.
66. Khambaty T, Stewart JC, Muldoon MF, Kamarck TW Depressive symptom clusters as predictors of 6-year increases in insulin resistance: data from the Pittsburgh Healthy Heart Project. Psychosom Med 2014, 76:363-369.
67. Kemp DE, Schinagle M, Gao K, et al. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression. CNS Drugs 2014, 28:571-581.
68. Kashani L, Omidvar T, Farazmand B, et al. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology 2013, 38:767-776.
69. Germain A, Kupfer DJ Circadian rhythm disturbances in depression. Hum Psychopharmacol 2008, 23:571-585.
70. Reutrakul S, Van Cauter E Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci 2014, 1311:151-173.
71. Prather AA, Vogelzangs N, Penninx BW Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA). J Psychiatr Res 2015, 60:95-102.
72. Hall MH, Muldoon MF, Jennings JR, Buysse DJ, Flory JD, Manuck SB Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 2008, 31:635-643.
73. Kudlow PA, Cha DS, Lam RW, McIntyre RS Sleep architecture variation: a mediator of metabolic disturbance in individuals with major depressive disorder. Sleep Med 2013, 14:943-949.
74. Modell S, Ising M, Holsboer F, Lauer CJ The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry 2005, 58:694-699.
75. Karthikeyan R, Marimuthu G, Spence DW, et al. Should we listen to our clock to prevent type 2 diabetes mellitus?. Diabetes Res Clin Pract 2014, 106:182-190.
76. Stamenkovic JA, Olsson AH, Nagorny CL, et al. Regulation of core clock genes in human islets. Metabolism 2012, 61:978-985.
77. Bunney BG, Li JZ, Walsh DM, et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry 2015, 20:48-55.
78. Kivimäki M, Hamer M, Batty GD, et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care 2010, 33:2611-2616.
79. Kivimäki M, Batty GD, Jokela M, et al. Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?. Biol Psychiatry 2011, 70:978-984.
80. Deuschle M Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry 2013, 26:60-65.
81. Lustman PJ, Clouse RE, Nix BD, et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521-529.
82. Snoek FJ, van der Ven NC, Twisk JW, et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet Med 2008, 25:1337-1342.
83. Winkley K, Ismail K, Landau S, Eisler I Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006, 333:65.
84. Georgiades A, Zucker N, Friedman KE, et al. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007, 69:235-241.
85. Korczak DJ, Pereira S, Koulajian K, Matejcek A, Giacca A Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia 2011, 54:2483-2493.
86. Hood KK, Lawrence JM, Anderson A, et al. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care 2012, 35:2443-2446. the SEARCH for Diabetes in Youth Study Group.
87. Worrall-Davies A, Owens D, Holland P, Haigh D The effect of parental expressed emotion on glycaemic control in children with Type 1 diabetes. Parental expressed emotion and glycaemic control in children. J Psychosom Res 2002, 52:107-113.
88. Lawton J, Waugh N, Barnard KD, et al. Challenges of optimizing glycaemic control in children with Type 1 diabetes: a qualitative study of parents' experiences and views. Diabet Med 2014, published online Dec 4. 10.1111/dme.12660.
89. Armstrong B, Mackey ER, Streisand R Parenting behavior, child functioning, and health behaviors in preadolescents with type 1 diabetes. J Pediatr Psychol 2011, 36:1052-1061.
90. Sassmann H, de Hair M, Danne T, Lange K Reducing stress and supporting positive relations in families of young children with type 1 diabetes: a randomized controlled study for evaluating the effects of the DELFIN parenting program. BMC Pediatr 2012, 12:152.
91. Bowlby J Attachment and Loss. Separation: Anxiety and Anger 1973, vol 2. Basic Books, New York.
92. Ciechanowski PS, Hirsch IB, Katon WJ Interpersonal predictors of HbA(1c) in patients with type 1 diabetes. Diabetes Care 2002, 25:731-736.
93. Fonagy P, Moran GS, Lindsay MK, Kurtz AB, Brown R Psychological adjustment and diabetic control. Arch Dis Child 1987, 62:1009-1013.
94. Hood KK, Rausch JR, Dolan LM Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change. Pediatr Diabetes 2011, 12:718-723.
95. Bloch CA, Clemons P, Sperling MA Puberty decreases insulin sensitivity. J Pediatr 1987, 110:481-487.
96. Law GU, Walsh J, Queralt V, Nouwen A Adolescent and parent diabetes distress in type 1 diabetes: the role of self-efficacy, perceived consequences, family responsibility and adolescent-parent discrepancies. J Psychosom Res 2013, 74:334-339.
97. Frier BM Living with hypoglycaemia. Hypoglycaemia in Clinical Diabetes 2007, 309-332. JohnWiley and Sons, Chichester, UK. 2nd edn. B.M. Frier, M. Fisher (Eds.).
98. Grey M, Boland EA, Davidson M, Li J, Tamborlane WV Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr 2000, 137:107-113.
99. Murphy HR, Rayman G, Skinner TC Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med 2006, 23:935-943.
100. Tsiouli E, Alexopoulos EC, Stefanaki C, Darviri C, Chrousos GP Effects of diabetes-related family stress on glycemic control in young patients with type 1 diabetes: systematic review. Can Fam Physician 2013, 59:143-149.
101. Maas-van Schaaijk NM, Roeleveld-Versteegh AB, van Baar AL The interrelationships among paternal and maternal parenting stress, metabolic control, and depressive symptoms in adolescents with type 1 diabetes mellitus. J Pediatr Psychol 2013, 38:30-40.
102. Miller D, Carlton BS The etiology and treatment of anorexia nervosa. Adolesc Psychiatry 1985, 12:219-232.
103. Powers MA, Richter S, Ackard D, Gerken S, Meier M, Criego A Characteristics of persons with an eating disorder and type 1 diabetes and psychological comparisons with persons with an eating disorder and no diabetes. Int J Eat Disord 2012, 45:252-256.
104. Colton PA, Olmsted MP, Daneman D, Rodin GM Depression, disturbed eating behavior, and metabolic control in teenage girls with type 1 diabetes. Pediatr Diabetes 2013, 14:372-376.
105. Corathers SD, Kichler J, Jones NH, et al. Improving depression screening for adolescents with type 1 diabetes. Pediatrics 2013, 132:e1395-e1402.
106. Zduńczyk B, Sendela J, Szypowska A High prevalence of depressive symptoms in well-controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabetes Metab Res Rev 2014, 30:333-338.
107. Johnson B, Eiser C, Young V, Brierley S, Heller S Prevalence of depression among young people with type 1 diabetes: a systematic review. Diabet Med 2013, 30:199-208.
108. Strandberg RB, Graue M, Wentzel-Larsen T, Peyrot M, Rokne B Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes. J Psychosom Res 2014, 77:174-179.
109. Trief PM, Xing D, Foster NC, et al. Depression in adults in the T1D Exchange Clinic Registry. Diabetes Care 2014, 37:1563-1572. the T1D Exchange Clinic Network.